Partner Sharon Masling spoke to CNBC after the US Food and Drug Administration (FDA) approved Pfizer’s COVID-19 vaccine for children ages 12–15 years. “Some school districts are going to want to be aggressive and see requiring vaccines as the way back to normal, whereas other districts may want to move more slowly, especially in areas where there is a lot of vaccine hesitancy,” Sharon said in the article.